NPS PHARMACEUTICALS INC Debt Instrument, Fair Value Disclosure
NPS PHARMACEUTICALS INC had Debt Instrument, Fair Value Disclosure of $110.29 million as of 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2015-02-18
- 2014-12-31: Debt Instrument, Fair Value Disclosure $110.29M.
- 2014-09-30: Debt Instrument, Fair Value Disclosure $119.23M.
- 2014-06-30: Debt Instrument, Fair Value Disclosure $130.34M.
- 2014-03-31: Debt Instrument, Fair Value Disclosure $225.66M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2014-12-31 | $110.29M 10-K · filed 2015-02-18 |
| 2014-09-30 | $119.23M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $130.34M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $225.66M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $233.84M 10-K · filed 2015-02-18 |
| 2013-09-30 | $223.59M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $184.03M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $175.29M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $184.75M 10-K · filed 2014-02-18 |
| 2012-09-30 | $184.41M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $189.89M 10-Q · filed 2012-08-01 |
| 2011-12-31 | $243.57M 10-K · filed 2013-02-21 |